Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.560
0.00 (0.00%)
Apr 8, 2026, 10:32 AM EDT - Market open
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $337.6 million as of April 8, 2026. Its market cap has increased by 1,017.88% in one year.
Market Cap
337.60M
Enterprise Value
260.57M
1-Year Change
1,017.88%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $337.60M, an increase of 12.01%. That is a compound annual growth rate of 1.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 337.60M | 190.78% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 306.76M |
| LENZ Therapeutics | 303.20M |
| Adlai Nortye | 301.84M |
| Foghorn Therapeutics | 289.39M |
| Prelude Therapeutics | 285.57M |
| Silence Therapeutics | 280.57M |
| NovaBridge Biosciences | 280.16M |
| Anavex Life Sciences | 277.09M |